BR9508805A - Composto uso do mesmo composto farmacêutica e processo de estímulo de liberação de hormônio de crescimento da pituitária e de produção de preparação útil no tratamento de complicações ou distúrbios resultantes de deficiência em hormônio de crescimento - Google Patents
Composto uso do mesmo composto farmacêutica e processo de estímulo de liberação de hormônio de crescimento da pituitária e de produção de preparação útil no tratamento de complicações ou distúrbios resultantes de deficiência em hormônio de crescimentoInfo
- Publication number
- BR9508805A BR9508805A BR9508805A BR9508805A BR9508805A BR 9508805 A BR9508805 A BR 9508805A BR 9508805 A BR9508805 A BR 9508805A BR 9508805 A BR9508805 A BR 9508805A BR 9508805 A BR9508805 A BR 9508805A
- Authority
- BR
- Brazil
- Prior art keywords
- growth hormone
- compound
- pituitary
- complications
- stimulating
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 2
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 206010056438 Growth hormone deficiency Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000000122 growth hormone Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000001817 pituitary effect Effects 0.000 title 1
- 230000004936 stimulating effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK95294 | 1994-08-17 | ||
| PCT/DK1995/000332 WO1996005195A1 (en) | 1994-08-17 | 1995-08-17 | Novel n-substituted naphthofused lactams |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9508805A true BR9508805A (pt) | 1998-01-06 |
Family
ID=8099355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9508805A BR9508805A (pt) | 1994-08-17 | 1995-08-17 | Composto uso do mesmo composto farmacêutica e processo de estímulo de liberação de hormônio de crescimento da pituitária e de produção de preparação útil no tratamento de complicações ou distúrbios resultantes de deficiência em hormônio de crescimento |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5817654A (cg-RX-API-DMAC10.html) |
| EP (1) | EP0777668A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JPH10504293A (cg-RX-API-DMAC10.html) |
| CN (1) | CN1158127A (cg-RX-API-DMAC10.html) |
| AU (1) | AU697003B2 (cg-RX-API-DMAC10.html) |
| BR (1) | BR9508805A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2196877A1 (cg-RX-API-DMAC10.html) |
| CZ (1) | CZ45897A3 (cg-RX-API-DMAC10.html) |
| HU (1) | HUT76645A (cg-RX-API-DMAC10.html) |
| IL (1) | IL114955A (cg-RX-API-DMAC10.html) |
| MX (1) | MX9701187A (cg-RX-API-DMAC10.html) |
| NO (1) | NO970684L (cg-RX-API-DMAC10.html) |
| PL (1) | PL318633A1 (cg-RX-API-DMAC10.html) |
| TW (1) | TW321640B (cg-RX-API-DMAC10.html) |
| WO (1) | WO1996005195A1 (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA956869B (cg-RX-API-DMAC10.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6211174B1 (en) | 1997-10-31 | 2001-04-03 | Merck & Co., Inc. | Naphtho-fused lactams promote release of growth hormone |
| US6380184B1 (en) | 1998-10-28 | 2002-04-30 | Bristol-Myers Squibb Co. | Benzoazepines and analogs thereof useful as growth hormone secretagogues |
| KR100699404B1 (ko) | 1999-02-18 | 2007-03-23 | 가켄 세야쿠 가부시키가이샤 | 성장 호르몬 분비촉진제로서의 신규 아미드 유도체 |
| US6518292B1 (en) | 1999-03-12 | 2003-02-11 | Bristol-Myers Squibb Co. | Heterocyclic aromatic compounds usefuls as growth hormone secretagogues |
| US6525203B1 (en) | 1999-03-12 | 2003-02-25 | Bristol-Myers Squibb Company | Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| JP2003504428A (ja) * | 1999-06-30 | 2003-02-04 | ハミルトン シビック ホスピタルズ リサーチ ディベロップメント インコーポレイテッド | クロット関連凝固因子を阻害するヘパリン組成物 |
| ES2252230T3 (es) | 2000-05-11 | 2006-05-16 | Bristol-Myers Squibb Company | Analogos de tetrahidroisoquinolina utiles como secretores de la hormona del crecimiento. |
| CN1473061A (zh) * | 2000-09-08 | 2004-02-04 | ���ܶ�����ҽԺ�о���չ����˾ | 抗血栓形成的组合物 |
| WO2003041641A2 (en) | 2001-11-09 | 2003-05-22 | Bristol-Myers Squibb Company | Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity |
| WO2013190520A2 (en) | 2012-06-22 | 2013-12-27 | The General Hospital Corporation | Gh-releasing agents in the treatment of vascular stenosis and associated conditions |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| WO2017075535A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
| MY196648A (en) | 2016-02-05 | 2023-04-27 | Denali Therapeutics Inc | Inhibitors of Receptor-Interacting Protein Kinase 1 |
| CN110383066B (zh) | 2016-12-09 | 2023-03-31 | 戴纳立制药公司 | 化合物、组合物和方法 |
| AU2023206890A1 (en) | 2022-01-12 | 2024-08-22 | Denali Therapeutics Inc. | Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5206235A (en) * | 1991-03-20 | 1993-04-27 | Merck & Co., Inc. | Benzo-fused lactams that promote the release of growth hormone |
| US5583130A (en) * | 1992-09-25 | 1996-12-10 | Merck & Co., Inc. | Benzo-fused lactams promote release of growth hormone |
-
1995
- 1995-08-16 IL IL11495595A patent/IL114955A/xx active IP Right Grant
- 1995-08-17 HU HU9701234A patent/HUT76645A/hu unknown
- 1995-08-17 BR BR9508805A patent/BR9508805A/pt not_active Application Discontinuation
- 1995-08-17 AU AU31618/95A patent/AU697003B2/en not_active Ceased
- 1995-08-17 CN CN95195133A patent/CN1158127A/zh active Pending
- 1995-08-17 CZ CZ97458A patent/CZ45897A3/cs unknown
- 1995-08-17 ZA ZA956869A patent/ZA956869B/xx unknown
- 1995-08-17 MX MX9701187A patent/MX9701187A/es unknown
- 1995-08-17 CA CA002196877A patent/CA2196877A1/en not_active Abandoned
- 1995-08-17 JP JP8506935A patent/JPH10504293A/ja active Pending
- 1995-08-17 PL PL95318633A patent/PL318633A1/xx unknown
- 1995-08-17 WO PCT/DK1995/000332 patent/WO1996005195A1/en not_active Ceased
- 1995-08-17 EP EP95927662A patent/EP0777668A1/en not_active Ceased
- 1995-09-15 TW TW084109669A patent/TW321640B/zh active
-
1997
- 1997-01-29 US US08/790,133 patent/US5817654A/en not_active Expired - Fee Related
- 1997-02-14 NO NO970684A patent/NO970684L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW321640B (cg-RX-API-DMAC10.html) | 1997-12-01 |
| AU697003B2 (en) | 1998-09-24 |
| MX9701187A (es) | 1997-05-31 |
| WO1996005195A1 (en) | 1996-02-22 |
| IL114955A0 (en) | 1995-12-08 |
| JPH10504293A (ja) | 1998-04-28 |
| NO970684D0 (no) | 1997-02-14 |
| CA2196877A1 (en) | 1996-02-22 |
| CN1158127A (zh) | 1997-08-27 |
| HUT76645A (en) | 1997-10-28 |
| ZA956869B (en) | 1996-04-10 |
| US5817654A (en) | 1998-10-06 |
| EP0777668A1 (en) | 1997-06-11 |
| IL114955A (en) | 1999-12-22 |
| PL318633A1 (en) | 1997-06-23 |
| AU3161895A (en) | 1996-03-07 |
| CZ45897A3 (en) | 1997-10-15 |
| NO970684L (no) | 1997-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9508805A (pt) | Composto uso do mesmo composto farmacêutica e processo de estímulo de liberação de hormônio de crescimento da pituitária e de produção de preparação útil no tratamento de complicações ou distúrbios resultantes de deficiência em hormônio de crescimento | |
| HUP0100069A3 (en) | 4(3)substituted-4(3)-aminomethyl-pyran, or -thiopyran-piperidine derivatives, their preparation and their use in the treatment of neurological disorders | |
| FI904092A7 (fi) | Lääkevalmisteita ankarien kiputilojen käsittelyyn ja menetelmä niiden valmistamiseksi | |
| AU674894C (en) | Treatment of conditions and disease | |
| BR9612204A (pt) | Composto uso do composto composição farmacêutica e processo para preparação do composto e para o tratamento de dor | |
| IL122733A0 (en) | Pharmaceutical compositions for use in the treatment of allergic asthma | |
| KR100206481B1 (en) | Galenic form for ocular administration and process for the preparation of same | |
| AU2187992A (en) | Composition and method for disease treatment | |
| AU6747790A (en) | Extraluminal regulation of the growth and repair of tubular structures in vivo | |
| GR980300033T1 (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
| CA2045594A1 (en) | Immunogenic compositions against gastrin peptides | |
| BR9708607A (pt) | Composto composição farmacéutica utilização de um composto processo para tratamento ou redução do risco de doença inflamatória num paciente e para a preparação de um composto e intermediário químico | |
| BR9502471A (pt) | Composto de guanidina processo para preparar um composto de guanidina composição farmaceutica uso de um composto de guanidina método para o tratamento profilático ou terapêutico de doenças e processo para preparar uma composição farmacêutica | |
| BR9506581A (pt) | Composto composição farmacêutica uso do composto processo para a profilaxia ou tratamento de uma condição clínica em um manífero por exemplo um humano e para a preparação de um composto e composto intermediário | |
| HUP9900654A3 (en) | Preparations stimulating nail growth, process for their preparation and use of them | |
| EP0424534A4 (en) | Pharmaceutical preparation for treatment of mastitis in animals and humans | |
| BR9710376A (pt) | Composto antiviral uso do mesmo composi-Æo farmac-utica e processo para tratamento antiviral profil tico ou terap-utico de um animal humano ou nÆo humano | |
| FI955426A7 (fi) | Pintakäsittelytuotteet ja menetelmät niiden valmistamiseksi | |
| NO982727D0 (no) | PGE-holdige lyofiliserte liposomer for anvendelse i behandling av erektil dysfunksjon | |
| CZ63895A3 (en) | 5-vinyl-quinolone-carboxylic, 5-vinyl-naphthyridon-carboxylic, +5-ethinyl-quinolone-carboxylic and 5-ethinyl-naphthyridon-carboxylic acids, process of their preparation, medicaments in which said compounds are comprised and their use | |
| AU623165B2 (en) | Method of inhibiting the spread of disease and infection in structures | |
| BR9612206A (pt) | Composto uso do composto composição farmacêutica processo para preparação do composto e para o tratamento da dor | |
| BR9612234A (pt) | Composto processo para preparação do mesmo uso do composto e processos para tratamento de doenças das vias aéreas e tratamento ou profilaxia de glaucoma | |
| IL107764A0 (en) | Use of certain methanebisphosphonic acid derivatives in fracture healing | |
| AU6736096A (en) | 1(hetero)aryl-4-(condensed thiazol-2-ylalkyl)-piperazine derivatives, their preparation and their use in the treatment of 5-ht1a-receptor mediated disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
| FA8 | Dismissal: dismissal - article 36, par. 1 of industrial property law |